» Articles » PMID: 36258216

CapG Promoted Nasopharyngeal Carcinoma Cell Motility Involving Rho Motility Pathway Independent of ROCK

Overview
Publisher Biomed Central
Date 2022 Oct 18
PMID 36258216
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gelsolin-like capping actin protein (CapG) modulates actin dynamics and actin-based motility with a debatable role in tumorigenic progression. The motility-associated functions and potential molecular mechanisms of CapG in nasopharyngeal carcinoma (NPC) remain unclear.

Methods: CapG expression was detected by immunohistochemistry in a cohort of NPC tissue specimens and by Western blotting assay in a variety of NPC cell lines. Loss of function and gain of function of CapG in scratch wound-healing and transwell assays were performed. Inactivation of Rac1 and ROCK with the specific small molecular inhibitors was applied to evaluate CapG's role in NPC cell motility. GTP-bound Rac1 and phosphorylated-myosin light chain 2 (p-MLC2) were measured in the ectopic CapG overexpressing cells. Finally, CapG-related gene set enrichment analysis was conducted to figure out the significant CapG-associated pathways in NPC.

Results: CapG disclosed increased level in the poorly differentiated NPC tissues and highly metastatic cells. Knockdown of CapG reduced NPC cell migration and invasion in vitro, while ectopic CapG overexpression showed the opposite effect. Ectopic overexpression of CapG compensated for the cell motility loss caused by simultaneous inactivation of ROCK and Rac1 or inactivation of ROCK alone. GTP-bound Rac1 weakened, and p-MLC2 increased in the CapG overexpressing cells. Bioinformatics analysis validated a positive correlation of CapG with Rho motility signaling, while Rac1 motility pathway showed no significant relationship.

Conclusions: The present findings highlight the contribution of CapG to NPC cell motility independent of ROCK and Rac1. CapG promotes NPC cell motility at least partly through MLC2 phosphorylation and contradicts with Rac1 activation.

Citing Articles

MLC2: Physiological Functions and Potential Roles in Tumorigenesis.

Lu J, Li N, Zhang W Cell Biochem Biophys. 2025; .

PMID: 40089610 DOI: 10.1007/s12013-025-01721-6.


5'-UTR G-Quadruplex-Mediated Translation Regulation in Eukaryotes: Current Understanding and Methodological Challenges.

Kamzeeva P, Alferova V, Korshun V, Varizhuk A, Aralov A Int J Mol Sci. 2025; 26(3).

PMID: 39940956 PMC: 11818886. DOI: 10.3390/ijms26031187.


DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer.

Hsieh C, Li T, Li C, Chen S, Wei Y, Chiang N Oncogenesis. 2024; 13(1):34.

PMID: 39333078 PMC: 11436992. DOI: 10.1038/s41389-024-00537-y.


CAPG is a novel biomarker for early gastric cancer and is involved in the Wnt/β-catenin signaling pathway.

Long Y, Wu J, Shen Y, Gan C, Zhang C, Wang G Cell Death Discov. 2024; 10(1):15.

PMID: 38191512 PMC: 10774411. DOI: 10.1038/s41420-023-01767-6.

References
1.
Riento K, Ridley A . Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003; 4(6):446-56. DOI: 10.1038/nrm1128. View

2.
Janmey P . Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. Annu Rev Physiol. 1994; 56:169-91. DOI: 10.1146/annurev.ph.56.030194.001125. View

3.
Xiao Z, Li M, Li G, Fu Y, Peng F, Chen Y . Proteomic Characterization Reveals a Molecular Portrait of Nasopharyngeal Carcinoma Differentiation. J Cancer. 2017; 8(4):570-577. PMC: 5370501. DOI: 10.7150/jca.17414. View

4.
Lang Z, Chen Y, Zhu H, Sun Y, Zhang H, Huang J . Prognostic and clinicopathological significance of CapG in various cancers: Evidence from a meta-analysis. Pathol Res Pract. 2019; 215(12):152683. DOI: 10.1016/j.prp.2019.152683. View

5.
Westbrook J, Cairns D, Peng J, Speirs V, Hanby A, Holen I . CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment. J Natl Cancer Inst. 2016; 108(4). PMC: 4808632. DOI: 10.1093/jnci/djv360. View